Amalgamated Bank’s ALX Oncology ALXO Stock Holding History

Amalgamated Bank’s Portfolio ALXO Stock Details ALXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-897	Closed	-$1K	–	3016
2025 Q1	$1K	Hold	897	–	–	﹤0.01%	2897
2024 Q4	$1K	Hold	897	–	–	﹤0.01%	2938
2024 Q3	$2K	Hold	897	–	–	﹤0.01%	2922
2024 Q2	$5K	Hold	897	–	–	﹤0.01%	2738
2024 Q1	$10K	Sell	897 -974	-52%	-$13.7K	﹤0.01%	2420
2023 Q4	$28K	Sell	1,871 -184	-9%	-$1.75K	﹤0.01%	2489
2023 Q3	$10K	Hold	2,055	–	–	﹤0.01%	2886
2023 Q2	$15K	Hold	2,055	–	–	﹤0.01%	2860
2023 Q1	$9K	Sell	2,055 -498	-20%	-$3.77K	﹤0.01%	2826
2022 Q4	$29K	Hold	2,553	–	–	﹤0.01%	2628
2022 Q3	$24K	Hold	2,553	–	–	﹤0.01%	2754
2022 Q2	$21K	Sell	2,553 -345	-12%	-$3.76K	﹤0.01%	2840
2022 Q1	$49K	Buy	+2,898	New	+$49.5K	﹤0.01%	2490
2021 Q4	–	Sell	-3,155	Closed	-$233K	–	2162
2021 Q3	$233K	Buy	+3,155	New	+$210K	﹤0.01%	1939

Other funds holding ALXO

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Amalgamated Bank's ALXO Position: Q2 2025 in Review

Amalgamated Bank sold out of ALX Oncology (ALXO) in Q2 2025, closing a stake of 897 shares — an estimated $1K sold.

Amalgamated Bank first reported a position in ALXO in Q3 2021 and held it in 14 quarters. The position peaked at $233K in Q3 2021. 61 funds tracked by Wall St. Rank hold ALXO as of Q2 2025.

Amalgamated Bank reported no remaining ALX Oncology position as of Q2 2025 after selling out during the quarter.
Amalgamated Bank sold 897 ALX Oncology shares in Q2 2025, an estimated $1K.
Amalgamated Bank first reported a position in ALX Oncology in Q3 2021 and held it in 14 quarters.
Amalgamated Bank's ALX Oncology position peaked at $233K in Q3 2021.
61 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.